Advertisement
Advertisement

YARW

Y

Yarrow Bioscience, Inc. Common Stock

30.45
USD
Sponsored
0.00
0.00%
Jul 29, 14:10 UTC -4
Closed
exchange

Pre-Market

30.54

+0.09
+0.30%

Yarrow Bioscience, Inc. Common Stock Profile

Info & Links

CEO

David Domzalski

Headquarters

685 ROUTE 202/206, SUITE 301
BRIDGEWATER, NJ 08807, UNITED STATES

Industry

Other

Sector

Other

Auditor

Baker Tilly US, LLP

Share holders

7

Employees

10

Yarrow Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.02B

Enterprise Value

993.97M

Enterprise Value/EBITDA(ttm)

-40.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

--

Operating Margin(ttm)

--

Profit Margin(ttm)

--

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

--

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

454.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

454.00K

EBITDA(ttm)3

-24.82M

Net Income Available to Common(ttm)

-21.46M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

14.98%

S&P 500 Member

No

Stock Optionable

No

Total Shares Outstanding1

33.35M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

24.93M

Total Cash Per Share(mrq)

0.75

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

--

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

--

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement